The FDA is taking a new tack and began posting a list of makers of brand-name drugs that have been the target of complaints, to persuade them to “end the shenanigans,” in the commissioner’s words.
Read MoreValeant, the company whose enormous price increases on old drugs helped fuel public outrage over high drug costs and also bought then sold Raleigh-based Sprout Pharmaceuticals, is changing its name.
Read MoreSprout Pharmaceuticals is getting back into business as Sprout2 with 203 investors lining up to launch the company that was sold just two years ago to Valeant Pharmaceuticals for $1 billion
Read More
